首页> 外国专利> A METHOD TO MEASURE MYELOID SUPPRESSOR CELLS FOR DIAGNOSIS AND PROGNOSIS OF CANCER

A METHOD TO MEASURE MYELOID SUPPRESSOR CELLS FOR DIAGNOSIS AND PROGNOSIS OF CANCER

机译:一种测量骨髓抑制细胞的方法,用于癌症的诊断和预后

摘要

Ratio of neutrophils to lymphocytes (NLR) is here associated with immune suppression and decreased survival times in multiple solid tumors. Based on immune cell-specific DMRs and validated cell deconvolution algorithms, the NLR in blood from glioma patients was estimated and glioma patients had elevated mdNLR scores compared to controls. The patient mdNLR scores were increased in patients with grade IV tumors compared to grade II/III. High mdNLR scores were associated with shorter survival. Candidate single (myeloid-associated) gene loci that were highly correlated with the mdNLR were identified. Single myeloid differentiation loci provide a simpler and cheaper alternative to the mdNLR, which requires complex array data. Immunomethylomics are useful and more convenient than conventional cell analysis in profiling glioma risk and survival.
机译:中性粒细胞与淋巴细胞(NLR)的比例在这里与免疫抑制和多个实体瘤中生存时间的减少有关。基于免疫细胞特异性DMR和经过验证的细胞解卷积算法,估算了神经胶质瘤患者血液中的NLR,与对照组相比,神经胶质瘤患者的mdNLR得分升高。与II / III级相比,IV级肿瘤患者的mdNLR评分增加。 mdNLR分数高与生存期短有关。确定了与mdNLR高度相关的候选单个(与髓样相关的)基因位点。单个髓样分化基因座为mdNLR提供了更简单和更便宜的替代方法,后者需要复杂的数组数据。免疫甲基组学在分析神经胶质瘤风险和生存方面比常规细胞分析有用且更方便。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号